PRISM
206A.TPRISM BioLab Co.,LTD Price (206A.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
31,354,800
(13.5979)%2024 - Income Statement Summary
| Revenue | 305.62M USD |
| Cost of Revenue | 145.08M USD |
| Gross Profit | 160.54M USD |
| Operating Expenses | 942.93M USD |
| Operating Income | -782392000.00 USD |
| Other Expenses | 942.93M USD |
| Net Income | -1049514000.00 USD |
Income Statement
PRISM BioLab Co.,LTDCurrency: JPY
| YEAR | 2022 | 2023 | 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
554,396,000.00
+0% |
112,926,000.00
-80% |
305,620,000.00
+171% |
||||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 19,259,000.00 | 32,620,000.00 | 145,080,000.00 | ||||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
535,137,000.00
+0% |
80,306,000.00
-85% |
160,540,000.00
+100% |
||||||||||||||||
| Gross Profit Ratio | (0.97%) | (0.71%) | (0.53%) | ||||||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 338,734,000.00 | 0.00 | ||||||||||||||||
| General and Administrative | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Selling, General & Admin... | 0.00 | 238,081,000.00 | 0.00 | ||||||||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Depreciation and Amortiz... | 1,208,000.00 | 8,737,000.00 | 0.00 | ||||||||||||||||
| Other Expenses | -1,496,000.00 | 0.00 | 942,932,000.00 | ||||||||||||||||
| Total Operating Expenses | 468,454,000.00 | 577,174,000.00 | 942,932,000.00 | ||||||||||||||||
| Cost and Exponses | 487,713,000.00 | 609,794,000.00 | 1,088,012,000.00 | ||||||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
66,681,000.00
+0% |
-496,868,000.00
-845% |
-782,392,000.00
+57% |
||||||||||||||||
| Operating Income Ratio | (0.12%) | (-4.40%) | (-2.56%) | ||||||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 21,000.00 | 19,000.00 | 356,000.00 | ||||||||||||||||
| Interest Expenses | 0.00 | 0.00 | 13,497,000.00 | ||||||||||||||||
| Total Other Income/Exp... | 7,476,000.00 | -28,836,000.00 | -265,811,000.00 | ||||||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 67,890,000.00 | -488,132,000.00 | -782,392,000.00 | ||||||||||||||||
| EBITDA ratio | (0.13%) | (-4.32%) | (-2.56%) | ||||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 74,157,000.00 | -525,704,000.00 | -1,048,203,000.00 | ||||||||||||||||
| Income Before Tax Ratio | (0.13%) | (-4.66%) | (-3.43%) | ||||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 1,194,000.00 | 1,210,000.00 | 1,310,000.00 | ||||||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 72,962,000.00
+0% |
-526,914,000.00
-822% |
-1,049,514,000.00
+99% |
||||||||||||||||
| Net Income Ratio | (0.13%) | (-4.67%) | (-3.43%) | ||||||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.00 | -14.90 | -33.47 | ||||||||||||||||
| Diluted EPS | 0.00 | -19.09 | -33.47 | ||||||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 0.00 | 35,354,800.00 | 31,354,800.00 | ||||||||||||||||
| Diluted Share Outstanding | 0.00 | 27,601,572.00 | 31,354,800.00 | ||||||||||||||||